Literature DB >> 23337935

Resveratrol facilitates pain attenuation in a rat model of neuropathic pain through the activation of spinal Sirt1.

Qin Yin1, Fei-Fei Lu, Yu Zhao, Ming-Yue Cheng, Qin Fan, Jie Cui, Lei Liu, Wei Cheng, Chang-Dong Yan.   

Abstract

BACKGROUND: Little research has been conducted regarding the implications of Sirt1 (a classic III HDAC) in neuropathic pain. The aim of this study was to investigate the variation in the expressions of spinal Sirt1 and acetyl-histone H3 in a rat model of chronic constriction injury.
METHODS: A neuropathic pain model of chronic constriction injury (CCI) was established in a unilateral hind limb in Sprague-Dawley rats.
RESULTS: Western blot analysis and immunohistochemistry revealed that Sirt1 (silent information regulator) expression decreased, whereas acetyl-histone H3 increased in the spinal cord following CCI surgery. The intrathecal administration of resveratrol, an activator of Sirt1, attenuated CCI-induced mechanical allodynia and thermal hyperalgesia, increased Sirt1 expression, and decreased acetyl-histone H3 in the spine. Resveratrol induced no obvious histopathological changes in the spinal cord.
CONCLUSIONS: Our data provide new evidence for the contribution of spinal Sirt1 to the initiation and maintenance of neuropathic pain. The antinociceptive effects of resveratrol may be mediated through the activation of spinal Sirt1 in CCI rats.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23337935     DOI: 10.1097/AAP.0b013e3182795b23

Source DB:  PubMed          Journal:  Reg Anesth Pain Med        ISSN: 1098-7339            Impact factor:   6.288


  23 in total

1.  SIRT1 Decreases Emotional Pain Vulnerability with Associated CaMKIIα Deacetylation in Central Amygdala.

Authors:  Chenghua Zhou; Yuqing Wu; Xiaobao Ding; Naihao Shi; Youqin Cai; Zhizhong Z Pan
Journal:  J Neurosci       Date:  2020-01-31       Impact factor: 6.167

Review 2.  Epigenetic regulation of chronic pain.

Authors:  Lingli Liang; Brianna Marie Lutz; Alex Bekker; Yuan-Xiang Tao
Journal:  Epigenomics       Date:  2015       Impact factor: 4.778

3.  The analgesic effect of trans-resveratrol is regulated by calcium channels in the hippocampus of mice.

Authors:  Weijie Wang; Yingcong Yu; Jing Li; Lin Wang; Zhi Li; Chong Zhang; Linlin Zhen; Lianshu Ding; Gang Wang; Xiaoyang Sun; Ying Xu
Journal:  Metab Brain Dis       Date:  2017-06-12       Impact factor: 3.584

4.  Naringenin Ameliorates Chronic Sleep Deprivation-Induced Pain via Sirtuin1 Inhibition.

Authors:  Shiyana Arora; Aishwarya Venugopalan; Ravinder Naik Dharavath; Mahendra Bishnoi; Kanthi Kiran Kondepudi; Kanwaljit Chopra
Journal:  Neurochem Res       Date:  2021-02-18       Impact factor: 3.996

Review 5.  Recent development in antihyperalgesic effect of phytochemicals: anti-inflammatory and neuro-modulatory actions.

Authors:  Ajeet Kumar Singh; Sanjay Kumar; Manjula Vinayak
Journal:  Inflamm Res       Date:  2018-05-16       Impact factor: 4.575

6.  Intrathecal Injection of SIRT1-modified Human Mesenchymal Stem Cells Alleviates Neuropathic Pain in Rat.

Authors:  Jun Tian; Tieying Song; Hong Wang; Wenli Wang; Zaiwang Zhang; Ruyu Yan; Xiaojing Ma; Yue Hu
Journal:  J Mol Neurosci       Date:  2020-10-02       Impact factor: 3.444

Review 7.  Epigenetic regulation of persistent pain.

Authors:  Guang Bai; Ke Ren; Ronald Dubner
Journal:  Transl Res       Date:  2014-05-29       Impact factor: 7.012

8.  Spinal SIRT1 activation attenuates neuropathic pain in mice.

Authors:  Haijun Shao; Qingsheng Xue; Fujun Zhang; Yan Luo; Hao Zhu; Xiaoqing Zhang; Honghai Zhang; Wenlong Ding; Buwei Yu
Journal:  PLoS One       Date:  2014-06-24       Impact factor: 3.240

9.  Intrathecal Injection of Resveratrol Attenuates Burn Injury Pain by Activating Spinal Sirtuin 1.

Authors:  Wei Cheng; Jin-Feng Wang; Cong-Xian Yang; Liang Wu; Qin Yin; He Liu; Zhi-Jian Fu
Journal:  Pharmacogn Mag       Date:  2016-05-11       Impact factor: 1.085

Review 10.  Food-Derived Natural Compounds for Pain Relief in Neuropathic Pain.

Authors:  Eun Yeong Lim; Yun Tai Kim
Journal:  Biomed Res Int       Date:  2016-11-07       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.